A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients (AMICI)
This study has been terminated.
(This study was terminated early due to poor enrollment.)
First Posted: June 19, 2007
Last Update Posted: July 22, 2011
Information provided by: